agilon health (AGL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Feb, 2026Executive summary
A special meeting of stockholders will be held virtually on March 17, 2026, to vote on two key proposals: a reverse stock split and the potential adjournment of the meeting if more time is needed for proxy solicitation.
The reverse stock split proposal seeks authorization for the board to effect a split at a ratio between one-for-five and one-for-twenty-five, without reducing the authorized number of shares.
The board recommends voting in favor of both proposals, citing improved marketability and compliance with listing requirements as primary motivations.
Proxy materials and annual reports are available online, and shareholders can vote via internet, phone, or mail.
Voting matters and shareholder proposals
Proposal 1: Approve an amendment to the certificate of incorporation to effect a reverse stock split at a ratio set by the board within the specified range.
Proposal 2: Approve adjournment of the meeting if more time is needed to solicit votes for the reverse stock split.
Both proposals are considered routine matters, allowing brokers discretionary voting authority if no instructions are provided.
Approval of the reverse stock split requires more votes cast "for" than "against"; adjournment requires a majority of shares present or represented by proxy.
Board of directors and corporate governance
The board retains discretion to determine the exact split ratio and whether to implement the reverse stock split after shareholder approval.
The board may abandon the reverse stock split at any time before filing the amendment, even if approved by shareholders.
No director or executive officer has a substantial interest in the reverse stock split beyond their proportional share ownership.
Latest events from agilon health
- Shareholders approved a reverse stock split and adjournment proposal, both backed by the Board.AGL
EGM 202617 Mar 2026 - Transformation, data-driven care, and disciplined contracting set the stage for growth and stability.AGL
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Disciplined contracting, cost controls, and clinical programs drive margin gains amid elevated trends.AGL
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - 2025 losses and lower membership set up for breakeven EBITDA and margin gains in 2026.AGL
Q4 202525 Feb 2026 - Stockholders to vote on a reverse stock split, reducing shares to as low as 16.6 million.AGL
Proxy Filing20 Feb 2026 - Virtual vote on reverse stock split and adjournment proposal to maintain NYSE compliance.AGL
Proxy Filing18 Feb 2026 - Q2 revenue up 39% to $1.5B, but net loss widened and margins declined on higher costs.AGL
Q2 20242 Feb 2026 - Value-based care model drives growth, efficiency, and improved outcomes amid industry shifts.AGL
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Cost trends are improving, membership is growing, and clinical initiatives are reducing utilization.AGL
2024 Wells Fargo Healthcare Conference22 Jan 2026